MEIP-- up another 5% today, printing some low 4.90s after some of us were buying in 3.70s and a lucky few got in the 3.60s after the s/p drop from $7s and $8s in Dec and Nov.
This one should continue to run back up to at least the upper $5s or $6s leading into the topline results for the Phase 2 trial of Pracinostat for MDS (with full data for both MDS and AML in June).
I pulled all auto-sell orders for this one. Just when one thinks it's gonna retrace down to test a lower support, it zooms up. Obviously "someone" was keeping the stock down sub-$4s in Dec. and Jan., and now obviously "someone" (or a bunch of someones) wants this to run back up...